A versatile synthetic dimerizer for the regulation of protein-protein interactions.

The use of low molecular weight organic compounds to induce dimerization or oligomerization of engineered proteins has wide-ranging utility in biological research as well as in gene and cell therapies. Chemically induced dimerization can be used to activate intracellular signal transduction pathways or to control the activity of a bipartite transcription factor. Dimerizer systems based on the natural products cyclosporin, FK506, rapamycin, and coumermycin have been described. However, owing to the complexity of these compounds, adjusting their binding or pharmacological properties by chemical modification is difficult. We have investigated several families of readily prepared, totally synthetic, cell-permeable dimerizers composed of ligands for human FKBP12. These molecules have significantly reduced complexity and greater adaptability than natural product dimers. We report here the efficacies of several of these new synthetic compounds in regulating two types of protein dimerization events inside engineered cells--induction of apoptosis through dimerization of engineered Fas proteins and regulation of transcription through dimerization of transcription factor fusion proteins. One dimerizer in particular, AP1510, proved to be exceptionally potent and versatile in all experimental contexts tested.

[1]  K. Peterson,et al.  A proliferation switch for genetically modified cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Schreiber,et al.  Specific Triggering of the Fas Signal Transduction Pathway in Normal Human Keratinocytes* , 1996, The Journal of Biological Chemistry.

[3]  M. Farrar,et al.  Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization , 1996, Nature.

[4]  P. J. Belshaw,et al.  Oligomerization activates c-Raf-1 through a Ras-dependent mechanism , 1996, Nature.

[5]  S. Schreiber,et al.  Controlling programmed cell death with a cyclophilin-cyclosporin-based chemical inducer of dimerization. , 1996, Chemistry & biology.

[6]  Shannon R. Magari,et al.  A humanized system for pharmacologic control of gene expression , 1996, Nature Medicine.

[7]  S. Schreiber,et al.  Dimeric ligands define a role for transcriptional activation domains in reinitiation , 1996, Nature.

[8]  S. Schreiber,et al.  Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization , 1996, Current Biology.

[9]  S. Schreiber,et al.  Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. M. Spencer.  Creating conditional mutations in mammals. , 1996, Trends in genetics : TIG.

[11]  S. Schreiber,et al.  A general strategy for producing conditional alleles of Src-like tyrosine kinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Schreiber,et al.  Signal transduction in T lymphocytes using a conditional allele of Sos. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Sharp,et al.  Structure-based design of transcription factors. , 1995, Science.

[14]  S. Schreiber,et al.  Proximity versus allostery: the role of regulated protein dimerization in biology. , 1994, Chemistry & biology.

[15]  Jon Clardy,et al.  DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS AND THE X-RAY CRYSTAL-STRUCTURES OF THEIR COMPLEXES WITH FKBP12. , 1994 .

[16]  S. Schreiber,et al.  Controlling signal transduction with synthetic ligands. , 1993, Science.

[17]  S. Nagata,et al.  A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. , 1993, The Journal of biological chemistry.

[18]  M. Gilman,et al.  Expression cloning of a novel zinc finger protein that binds to the c-fos serum response element , 1992, Molecular and cellular biology.

[19]  P. Baeuerle,et al.  The p65 subunit is responsible for the strong transcription activating potential of NF‐kappa B. , 1991, The EMBO journal.

[20]  O. Witte,et al.  BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias , 1991, Molecular and cellular biology.

[21]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.